文献速递内脏/肾动脉与血管畸形

弹簧圈栓塞治疗肾动脉分叉部及分支动脉瘤并保留血流

Coil embolization of renal artery bifurcation and branch aneurysms with flow preservation.
PubMed 文献 · J Vasc Surg · 2018-03-12

本回顾性研究比较了瘤囊填塞与弹簧圈孤立/流入阻断治疗肾动脉瘤的并发症与结局。52例患者中,瘤囊填塞组28例、弹簧圈孤立/流入阻断组24例;两组技术成功率均100%、院内死亡率均0%,但弹簧圈孤立/流入阻断组肾功能受损更常见(0% vs 15%;P = .049)。作者认为瘤囊填塞可能安全有效,且可能优于弹簧圈孤立/流入阻断。

要点

  • 瘤囊填塞组术后即刻内漏发生率28.6%,弹簧圈孤立/流入阻断组为8.3%(P = .065)。
  • 弹簧圈孤立/流入阻断组肾功能受损发生率为15%,瘤囊填塞组为0%(P = .049)。
  • 两组围术期并发症率(7.1% vs 16.7%;P = .284)及总发病率(12.5% vs 25%;P = .284)无统计学差异。

核心结论

  • 作者认为瘤囊填塞可能是治疗位于肾动脉主分叉或分支动脉的肾动脉瘤的安全有效方法,考虑到可能损失功能性肾实质,可能优于弹簧圈孤立/流入阻断。

研究设计与样本

  • 回顾性研究,纳入2003年6月至2017年5月在本中心接受弹簧圈栓塞治疗的肾动脉瘤患者52例,瘤囊填塞组28例,弹簧圈孤立/流入阻断组24例。

主要发现

  • 瘤囊填塞组与弹簧圈孤立/流入阻断组的平均动脉瘤直径分别为25.6 ± 8.4 mm和31.1 ± 16.8 mm(P = .130)。
  • 瘤囊填塞组67.9%的动脉瘤起源于肾动脉主分叉,弹簧圈孤立/流入阻断组54.2%起源于肾段分支动脉。
  • 两组即刻技术成功率均为100%,院内死亡率均为0%。
  • 瘤囊填塞组术后即刻内漏发生率为28.6%,弹簧圈孤立/流入阻断组为8.3%(P = .065)。
  • 瘤囊填塞组与弹簧圈孤立/流入阻断组的围术期并发症率分别为7.1%和16.7%(P = .284),总发病率分别为12.5%和25%(P = .284)。

关键数值与推荐

  • 瘤囊填塞组与弹簧圈孤立/流入阻断组的平均随访时间分别为37.67 ± 29.84个月和49.35 ± 28.11个月(P = .192)。
  • 两组均无肾动脉瘤相关死亡或动脉瘤破裂发生。
  • 部分肾梗死发生在瘤囊填塞组2例和弹簧圈孤立/流入阻断组5例(8.3% vs 25%;P = .132)。
  • 肾功能受损在弹簧圈孤立/流入阻断术后更常见(0% vs 15%;P = .049)。
  • 瘤囊填塞组1例患者在4个月时因瘤囊再灌注需要进一步干预(4.2% vs 0%;P = .356)。

临床怎么用

  • 作者认为瘤囊填塞可能是治疗位于肾动脉主分叉或分支动脉的肾动脉瘤的安全有效方法,且可能优于弹簧圈孤立/流入阻断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Coil embolization is one of the most common endovascular approaches to treatment of renal artery aneurysms (RAAs). The purpose of this retrospective study was to compare complications, mortality, and morbidity associated with sac packing, coil trapping, and inflow occlusion. METHODS: The records of all patients with RAAs treated with coil embolization at our center from June 2003 to May 2017 were retrospectively reviewed. Demographics of the patients, aneurysm characteristics, management strategies, perioperative and long-term outcomes, and complications were analyzed. RESULTS: A total of 52 patient records were reviewed; 28 patients received sac packing and 24 patients underwent coil trapping/inflow occlusion. There was no significant difference in patients' demographics or RAA characteristics between the groups. The mean aneurysm diameter was 25.6 ± 8.4 mm in the sac packing group and 31.1 ± 16.8 mm in the coil trapping/inflow occlusion group (P = .130). Most aneurysms in the sac packing group originated from the main renal artery bifurcation (67.9%), whereas in the coil trapping/inflow occlusion group, most aneurysms originated from the renal segmental branch arteries (54.2%). The immediate technical success rate was 100%, and the in-hospital mortality rate was 0% in both groups. Sac packing was more likely to be associated with endoleak immediately after the procedure (28.6% vs 8.3%; P = .065). The overall perioperative complication rate was not statistically different between the groups (7.1% vs 16.7%; P = .284). The mean duration of follow-up was 37.67 ± 29.84 months and 49.35 ± 28.11 months in the sac packing and coil trapping/inflow occlusion groups, respectively (P = .192). No deaths related to RAAs or aneurysm rupture occurred in either group. The overall morbidity rate was similar between groups (12.5% vs 25%; P = .284). Partial renal infarction occurred in two and five patients in the sac packing and coil trapping/inflow occlusion groups, respectively (8.3% vs 25%; P = .132). Impaired renal function was more frequent after coil trapping/inflow occlusion (0% vs 15%; P = .049). A single patient in the sac packing group required further intervention for reperfusion of the aneurysmal sac at 4 months (4.2% vs 0%; P = .356). CONCLUSIONS: Sac packing might be a safe and effective way to treat RAAs located at the main bifurcation or in branch arteries and may be preferable to coil trapping/inflow occlusion, considering the potential loss of functional renal mass.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Tang H, Tang X, Fu W, et al. Coil embolization of renal artery bifurcation and branch aneurysms with flow preservation. J Vasc Surg. 2018. PMID: 29544994. doi:10.1016/j.jvs.2017.12.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。